Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.
复制标题
DOI:
10.1007/s00262-008-0648-5
复制
发表时间:
2009-08
影响因子:
5.8
通讯作者:
Kalinski, Pawel
中科院分区:
文献类型:
--
作者:
Giermasz, Adam S.;Urban, Julie A.;Nakamura, Yutaro;Watchmaker, Payal;Cumberland, Rachel L.;Gooding, William;Kalinski, Pawel
While multiple pathways of dendritic cell (DC) maturation result in transient production of IL-12, fully mature DCs show reduced ability to produce IL-12p70 upon a subsequent interaction with Ag-specific T cells, limiting their in vivo performance as vaccines. Such “DC exhaustion” can be prevented by the presence of IFNγ during the maturation of human DCs (type-1-polarization), resulting in improved induction of tumor-specific Th1 and CTL responses in vitro. Here, we show that type-1 polarization of mouse DCs strongly enhances their ability to induce CTL responses against a model tumor antigen, OVA, in vivo, promoting the induction of protective immunity against OVA-expressing EG7 lymphoma. Interestingly, in contrast to the human system, the induction of mouse DC1s requires the participation of IL-4, a nominal Th2-inducing cytokine. The current data help to explain the previously reported Th1-driving and anti-tumor activities of IL-4, and demonstrate that type-1 polarization increases in vivo activity of DC-based vaccines.
登录
查看更多内容
DOI:
10.1084/jem.20030448
发表时间:
2003-08-18
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
MartIn-Fontecha A;Sebastiani S;Höpken UE;Uguccioni M;Lipp M;Lanzavecchia A;Sallusto F
通讯作者:
Sallusto F
影响因子:
6.4
作者:
Kiertscher, SM;Gitlitz, BJ;Roth, MD
通讯作者:
Roth, MD
影响因子:
30.5
作者:
Langenkamp, A;Messi, M;Sallusto, F
通讯作者:
Sallusto, F
影响因子:
4.4
作者:
Mailliard, RB;Son, YI;Kalinski, P
通讯作者:
Kalinski, P
影响因子:
30.5
作者:
Biedermann, T;Zimmermann, S;Röcken, M
通讯作者:
Röcken, M